Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Viral Mutations00:36

Viral Mutations

32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

4.7K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.7K
Homologous Recombination02:31

Homologous Recombination

50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic SERS Profiling under Triple-Coupled Hotspots Aided by Machine Learning for Precise Identification of Gastrointestinal Malignancies.

Analytical chemistry·2026
Same author

Accelerating the Discovery of Targeted Protein Degraders: Advances in Synthetic Methodologies and Screening Tactics.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Secoemestrin C exerts rapid and prominent anti-breast cancer effect in triple-negative breast cancer by inducing SLX4 and YAP degradation.

Acta pharmacologica Sinica·2026
Same author

Discovery of <b>DN1679</b> as a Potent, Orally Bioavailable, and Highly Selective CDK12/13 Dual Degrader for the Treatment of Triple-Negative Breast Cancer.

Journal of medicinal chemistry·2025
Same author

Multifaceted roles of HDAC7 in disease and the evolving chemical toolkit for its modulation.

Bioorganic & medicinal chemistry letters·2025
Same author

Phenotypic Screening for Targeted Protein Degradation: Strategies, Challenges, and Emerging Opportunities.

Journal of medicinal chemistry·2025

Related Experiment Video

Updated: Jul 4, 2025

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.3K

HBV promotes its replication by up-regulating RAD51C gene expression.

Ting-Wei Peng1, Qing-Feng Ma2, Jie Li3

  • 1Department of Clinical Laboratory, Shanghai Gongli Hospital, the Second Military Medical University, Shanghai, 200135, China.

Scientific Reports
|January 31, 2024
PubMed
Summary

Hepatitis B virus (HBV) infection promotes hepatocellular carcinoma (HCC) by increasing RAD51C expression, which in turn enhances viral replication. This interaction highlights RAD51C as a potential target for new HCC therapies.

More Related Videos

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.7K
Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
09:38

Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry

Published on: June 26, 2019

8.1K

Related Experiment Videos

Last Updated: Jul 4, 2025

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.3K
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.7K
Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
09:38

Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry

Published on: June 26, 2019

8.1K

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Chronic hepatitis B virus (HBV) infection is a primary driver of hepatocellular carcinoma (HCC).
  • Current treatments like pegylated-interferon-alpha (PEG-IFNα) and nucleos(t)ide analogs (NUCs) show limited efficacy.
  • RAD51C, involved in DNA repair, is upregulated in HBV-infected HCC cells, suggesting a role in tumorigenesis.

Purpose of the Study:

  • To investigate the relationship between HBV infection and abnormal RAD51C expression in HCC.
  • To elucidate the interaction between HBV and RAD51C in HCC cells.
  • To explore RAD51C as a potential therapeutic target for HBV-related HCC.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) to quantify gene expression.
  • Western blot analysis to detect protein levels.
  • Co-immunoprecipitation (Co-IP) to confirm protein interactions.
  • Immunofluorescence (IF) to visualize protein localization.

Main Results:

  • RAD51C directly interacts with the HBV X protein (HBX) within the nucleus.
  • HBV infection significantly increases RAD51C expression in HCC cells.
  • Elevated RAD51C expression promotes HBV replication.

Conclusions:

  • RAD51C plays a critical role in the development and progression of HBV-induced HCC.
  • The interaction between HBX and RAD51C is a key mechanism in HCC pathogenesis.
  • Targeting RAD51C may offer a novel therapeutic strategy for preventing and treating HBV-related HCC.